| Style | Citing Format |
|---|---|
| MLA | Farzaneh M, et al.. "An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers." Pathology Research and Practice, vol. 245, no. , 2023, pp. -. |
| APA | Farzaneh M, Masoodi T, Ghaedrahmati F, Radoszkiewicz K, Anbiyaiee A, Sheykhisabzehpoush M, Rad NK, Uddin S, Jooybari SPM, Khoshnam SE, Azizidoost S (2023). An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers. Pathology Research and Practice, 245(), -. |
| Chicago | Farzaneh M, Masoodi T, Ghaedrahmati F, Radoszkiewicz K, Anbiyaiee A, Sheykhisabzehpoush M, Rad NK, et al.. "An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers." Pathology Research and Practice 245, no. (2023): -. |
| Harvard | Farzaneh M et al. (2023) 'An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers', Pathology Research and Practice, 245(), pp. -. |
| Vancouver | Farzaneh M, Masoodi T, Ghaedrahmati F, Radoszkiewicz K, Anbiyaiee A, Sheykhisabzehpoush M, et al.. An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers. Pathology Research and Practice. 2023;245():-. |
| BibTex | @article{ author = {Farzaneh M and Masoodi T and Ghaedrahmati F and Radoszkiewicz K and Anbiyaiee A and Sheykhisabzehpoush M and Rad NK and Uddin S and Jooybari SPM and Khoshnam SE and Azizidoost S}, title = {An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers}, journal = {Pathology Research and Practice}, volume = {245}, number = {}, pages = {-}, year = {2023} } |
| RIS | TY - JOUR AU - Farzaneh M AU - Masoodi T AU - Ghaedrahmati F AU - Radoszkiewicz K AU - Anbiyaiee A AU - Sheykhisabzehpoush M AU - Rad NK AU - Uddin S AU - Jooybari SPM AU - Khoshnam SE AU - Azizidoost S TI - An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers JO - Pathology Research and Practice VL - 245 IS - SP - EP - PY - 2023 ER - |